We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

167 hedge funds and large institutions have $696M invested in Meridian Bioscience Inc in 2015 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 62 increasing their positions, 46 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 11

64% more call options, than puts

Call options by funds: $1.7M | Put options by funds: $1.04M

35% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 46

5% more funds holding

Funds holding: 159 → 167 (+8)

4% less capital invested

Capital invested by funds: $723M → $696M (-$27.5M)

Holders
167
Holders Change
+8
Holders Change %
+5.03%
% of All Funds
4.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
62
Reduced
46
Closed
11
Calls
$1.7M
Puts
$1.04M
Net Calls
+$666K
Net Calls Change
+$599K

Top Buyers

Rank Fund Capital Flow
1
PP
Prudential plc
United Kingdom
+$8.51M
2
Renaissance Technologies
Renaissance Technologies
New York
+$7.04M
3
MCM
McKinley Capital Management
Alaska
+$3.81M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.78M
5
Charles Schwab
Charles Schwab
California
+$3.73M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$40.9M
2
Neuberger Berman Group
Neuberger Berman Group
New York
-$4.93M
3
FAM
Fred Alger Management
New York
-$2.17M
4
Two Sigma Investments
Two Sigma Investments
New York
-$2.15M
5
Millennium Management
Millennium Management
New York
-$2M
Name Holding Trade Value Shares
Change 		Change in
Stake
MAA
176
Managed Account Advisors
New Jersey
– -$66K -3,420 Closed
PCM
177
Prelude Capital Management
New York
– -$36K -1,900 Closed
AF
178
Arrow Financial
New York
– -$2K -100 Closed
4 5 6 7
8

VIVO Hedge Fund Activity: Q2 2015 in Review

167 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2015, worth a combined $696M — down 3.8% from $723M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new VIVO positions and 11 closed out — a net gain of 9 holders — while 62 added to existing stakes and 46 trimmed.

The largest buyer was Prudential plc, adding an estimated $8.51M. The largest seller was Fidelity Investments, exiting entirely with an estimated $40.9M sold.

  • 167 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2015, up from 159 in Q1 2015.
  • Funds reported $696M of Meridian Bioscience Inc stock for Q2 2015, down 3.8% quarter-over-quarter.
  • 20 funds opened new Meridian Bioscience Inc positions in Q2 2015 and 11 closed out, a net change of +9 holders.
  • The largest Meridian Bioscience Inc buyer in Q2 2015 was Prudential plc, an estimated $8.51M added.
  • The largest Meridian Bioscience Inc seller in Q2 2015 was Fidelity Investments, an estimated $40.9M sold.

Based on aggregated 13F filings for Q2 2015.